Search the Newsreel

Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?

Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10.58 million to net income of US$28 million. Alongside this shift to profitability, the company …

United Hampshire US REIT (SGX:ODBU) Stock Profitability Masks Thin Interest Cover

Shenzhen Investment Holdings Bay Area Development Company Limited Reports Earnings Results for the Half Year Ended June 30, 2026

AG Mortgage Investment Trust, Inc. (NYSE:MITT) Given Consensus Rating of "Moderate Buy" by Brokerages

Apartment Investment And Management (AIV) Q4 2024 Earnings Report - Results, Call & Slides

Choice Properties Real Estate Investment Trust (TSX:CHP.UN) Could Be 26% Undervalued At Current Price

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Recent share performance and what it might signal Choice Properties Real Estate Investment Trust (TSX:CHP.UN) has drawn fresh attention after a period of mixed share performance, with …

Earnings Flash (TNT-UN.TO) True North Commercial Real Estate Investment Trust Reports Q2 Revenue C$27.9M

Grown Up Group Investment Sets Out Board and Committee Lineup

CapitaLand Investment Limited (9CI.SI) stock price, news, quote and history

SF Real Estate Investment Trust (SEHK:2191) Stock Recovers Profit As Revenue Softens

Earnings Flash (APR-UN.TO) Automotive Properties Real Estate Investment Trust Reports Q2 Revenue C$30.2M

Phoenix Media Revamps Board With Director Resignations and New Appointment

Phoenix Media Sets Independent Oversight for Executive Pay and Incentive Policies

Phoenix Media Investment Details Board Line-Up and Governance Committees

Gladstone Investment (NASDAQ:GAIN) Stock Rating Upgraded by Zacks Research

SLR Investment (NASDAQ:SLRC) Rating Lowered to Hold at B. Riley Financial

NewHold Investment Corp IV (NASDAQ: NHIV) posts Q2 2026 income on trust interest

Tube Investments of India Shares Fall 2.54% on Friday Afternoon

China Merchants China Direct Investments Updates Net Asset Value Per Share

SIL Investments Share Price Target 2027 to 2030: Analyst Outlook

BF Investment consolidated net profit rises 279.79% in the June 2026 quarter

The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From Clover Health's Q2 Earnings Call Clover Health's second quarter results were met with a positive market reaction, driven by strong Medicare Advantage membership growth and improved profitability. Management credited the quarter's performance to the expansion of its …

Killam Apartment REIT (TSX:KMP.UN) Could Be 29% Below Fair Value As Earnings Draw Focus

BF Investment Q1 Results: Consolidated net profit up 279% YoY to ₹1,460 crore

China Merchants China Direct Investments Sets Board Meeting to Review Interim Results and Dividend

TIINDIA: Q1 FY27 saw revenue growth, robust ROIC, and strategic acquisitions amid stable profitability

Magnificent Hotel Investments Withdraws Proposed Special Dividend After Deal Termination

Long Investment Corp flags HK$50–60 million interim loss on market and digital asset hits

Magnificent Hotel Investments Sets Board Meeting to Review Interim Results and Dividend

Shun Ho Property Sets August Board Meeting to Review Interim Results and Dividend

First Shanghai Sets Board Meeting to Approve Interim Results and Consider Dividend

Is Premier Investments (ASX:PMV) UK Exit Sharpening Its Australasian Focus Or Limiting Global Ambition?

Aehr Test Systems $AEHR Shares Sold by Sei Investments Co.

Sei Investments Co. reduced its stake in Aehr Test Systems (NASDAQ:AEHR) by 27.6% in the first quarter, selling 8,812 shares but retaining 23,109 shares valued at $857,000. Despite this, institutional investors and hedge funds still own a significant 69.69% of AEHR. The company has …

Sei Investments Co. Makes New Investment in Aclaris Therapeutics, Inc. $ACRS

Sei Investments Co. has initiated a new position in Aclaris Therapeutics, acquiring 217,154 shares valued at $814,000, representing 0.16% of the company. Institutional investors now collectively own 98.34% of Aclaris, which reported a narrower-than-expected quarterly loss and exceeded revenue estimates. Despite remaining unprofitable, analysts …

SIL Investments Q1 Results: Board approves Q1FY27 financials

Is Virtus Investment Partners (VRTS) Trading At A Discount Following Its Latest Asset Flow Update?